New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Nutex Health, Inc.
NUTX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

123M

Medical - Healthcare Information Services

Next Earning date - 14 Nov 2024

123M

Medical - Healthcare Information Services

Next Earning date - 14 Nov 2024

24.29USD
Shape-0.29 ( -1.18%)
favorite-chart

Relative Strenght

2
favorite-chart

Volume Buzz

-30%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

46%

Quote Panel

Shape
Updated October 26, 2024
1W 7.57 % 1M 23.13 % 3M 185.49 % 1Y -12.05 %

Key Metrics

Shape
  • Market Cap

    123.05M


  • Shares Outstanding

    5.07M


  • Share in Float

    2.90M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    24.29


  • Average Volume

    69739


  • Beta

    1.829


  • Range

    4.16-45.0


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.nutexhealth.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.45x

P/S Ratio

2.89x

P/B Ratio

0.8

Debt/Equity

-13.7%

Net Margin

$-9.0

EPS

How NUTX compares to sector?

P/E Ratio

Relative Strength

Shape

NUTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$348M

Shape358%

2025-Revenue

$1.50

Shape3174%

2025-EPS

$114M

Shape591%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Maxim Group

initialise

Previous: Not converted

2024-09-18

Now: Buy

Benchmark

initialise

Previous: Not converted

2022-12-23

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

NA
vs 0.08

Q4.22

arrow
arrow

N/A

-0.30
vs 0.02

Q1.23

arrow
arrow

N/A

-0.01
vs -0.03

Q2.23

arrow
arrow

N/A

-0.15
vs -0.45

Q3.23

arrow
arrow

N/A

NA
vs NA

Q4.23

arrow
arrow

N/A

-0.75
vs -0.30

Q1.24

arrow
arrow

N/A

-0.10
vs -0.01

Q2.24

arrow
arrow

N/A

-0.07
vs -0.15

Q3.24

arrow
arrow

N/A

-0.24
vs NA

Q4.24

arrow
arrow

N/A

-0.10
vs -0.75

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-76%

28.4M  vs 118M

Q4.22

arrow
arrow

-17%

53.7M  vs 65M

Q1.23

arrow
arrow

+807%

56.3M  vs 6.2M

Q2.23

arrow
arrow

+2%

58.9M  vs 58M

Q3.23

arrow
arrow

+121%

62.7M  vs 28.4M

Q4.23

arrow
arrow

+30%

69.7M  vs 53.7M

Q1.24

arrow
arrow

+20%

67.5M  vs 56.3M

Q2.24

arrow
arrow

+29%

76.1M  vs 58.9M

Q3.24

arrow
arrow

+17%

73.2M  vs 62.7M

Q4.24

arrow
arrow

+15%

80M  vs 69.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-392%

-3.92
vs -0.04

Q4.22

arrow
arrow

-11%

-0.11
vs -3.92

Q1.23

arrow
arrow

-6%

-0.06
vs -0.11

Q2.23

arrow
arrow

-4%

-0.04
vs -0.06

Q3.23

arrow
arrow

-6%

-0.06
vs -0.04

Q4.23

arrow
arrow

-51%

-0.51
vs -0.06

Q1.24

arrow
arrow

-1%

-0.01
vs -0.51

Q2.24

arrow
arrow

-1%

-0.01
vs -0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

50

50
vs 48

4%

Q4.22

arrow
arrow

77

77
vs 50

54%

Q1.23

arrow
arrow

84

84
vs 77

9%

Q2.23

arrow
arrow

74

74
vs 84

-12%

Q3.23

arrow
arrow

58

58
vs 74

-22%

Q4.23

arrow
arrow

49

49
vs 58

-16%

Q1.24

arrow
arrow

43

43
vs 49

-12%

Q2.24

arrow
arrow

2

2
vs 43

-95%

Earnings Growth

Latest News